安必平2025年度归母净亏损4497.17万元

Core Viewpoint - Anbiping (688393.SH) reported a significant decline in revenue and a shift to net loss for the fiscal year 2025, primarily due to the implementation of national procurement policies affecting product pricing and sales [1] Financial Performance - The total operating revenue for 2025 was 347 million yuan, representing a year-on-year decrease of 26.24% [1] - The net profit attributable to the parent company was a loss of 44.97 million yuan, a shift from profit to loss compared to the previous year [1] Business Impact - The HPV product line experienced a substantial price drop, leading to a revenue reduction of approximately 46.5 million yuan [1] - The company proactively optimized its business structure by focusing on core business revenue expansion and reducing the scale of agency product operations [1] Strategic Adjustments - To enhance market penetration, the company actively adjusted its channel strategy, increasing the proportion of distribution channels [1] - The sales price of products decreased year-on-year, which had a short-term negative impact on overall gross profit [1]